Your browser doesn't support javascript.
loading
From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.
Shi, Zhenfeng; Tian, Lei; Qiang, Taotao; Li, Jingyi; Xing, Yue; Ren, Xiaodong; Liu, Chang; Liang, Chengyuan.
Afiliação
  • Shi Z; Department of Urology Surgery Center, The People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi 830002, P. R. China.
  • Tian L; College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an 710021, P. R. China.
  • Qiang T; Faculty of Pharmacy, Shaanxi University of Science & Technology, Xi'an 710021, P. R. China.
  • Li J; College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an 710021, P. R. China.
  • Xing Y; Faculty of Pharmacy, Shaanxi University of Science & Technology, Xi'an 710021, P. R. China.
  • Ren X; Faculty of Pharmacy, Shaanxi University of Science & Technology, Xi'an 710021, P. R. China.
  • Liu C; Medical College, Guizhou University, Guiyang 550025, P. R. China.
  • Liang C; Zhuhai Jinan Selenium Source Nanotechnology Co., Ltd., Zhuhai 519030, P. R. China.
J Med Chem ; 65(9): 6390-6418, 2022 05 12.
Article em En | MEDLINE | ID: mdl-35485642

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Tipo de estudo: Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Tipo de estudo: Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article